technical aspects of percutaneous vertebroplasty dr. cosme argerich neurosurgeon

26
Technical Aspects of Technical Aspects of Percutaneous Percutaneous Vertebroplasty Vertebroplasty Dr. Cosme Argerich Neurosurgeon

Upload: tobias-lambert

Post on 27-Dec-2015

217 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

Technical Aspects of Technical Aspects of Percutaneous Percutaneous VertebroplastyVertebroplasty

Dr. Cosme ArgerichNeurosurgeon

Page 2: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

HistoryHistory

1987: First 1987: First descriptiondescription by Galibert and by Galibert and Deramond.Deramond.

1995: First procedure in Geneva 1995: First procedure in Geneva (Switzerland).(Switzerland).

1997 First reported procedure in USA.1997 First reported procedure in USA.

Page 3: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

SchoolsSchools

EuropeanEuropean38% methastases38% methastases31% Hemangiomas / 31% Hemangiomas / MyelomasMyelomas31% Osteoporosis31% Osteoporosis

North AmericanNorth American70% Osteoporosis70% Osteoporosis17% Hemangiomas / 17% Hemangiomas / MyelomasMyelomas13% Methastases13% Methastases

Page 4: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

DemographyDemographyUSAUSA

10 Million cases of Osteoporosis (45% 10 Million cases of Osteoporosis (45% white female > 50 years).white female > 50 years).

700 thousand vertebral fractures / year.700 thousand vertebral fractures / year.

150 thousand hospital admissions / year.150 thousand hospital admissions / year.

Total direct costs: U$ 13.800 Millions.Total direct costs: U$ 13.800 Millions.

Estimated costs in 2030: 60.000 Millions.Estimated costs in 2030: 60.000 Millions.

Page 5: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

Diagnostic SequenceDiagnostic Sequence

Clinic evaluation

Anamnesis

Physical exam

Clinical

Neurological

Lab tests

Page 6: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

Osteoporosis

Plain x-Rays Densitometry Metabolic Lab

Page 7: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

Tumors

CT MRI Markers

Biopsy?

Page 8: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

Indications for PVIndications for PV

Pain / instability in:Pain / instability in:

Osteoporotic collapse.Osteoporotic collapse.

Sub-acute traumatic collapse.Sub-acute traumatic collapse.

Malignant vertebral tumors (Metastasis / Malignant vertebral tumors (Metastasis / Myeloma)Myeloma)

Vertebral angiomas Vertebral angiomas

Page 9: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

OsteoporosisOsteoporosis

Intense and persistent post fractural pain: Intense and persistent post fractural pain: 1 to 12 weeks evolution.1 to 12 weeks evolution.

Pain focused on spinal mid-line, related to Pain focused on spinal mid-line, related to diagnosed vertebral collapse.diagnosed vertebral collapse.

Absence / poor response to medical Absence / poor response to medical therapy (Alendronate, Calcium, Opiates).therapy (Alendronate, Calcium, Opiates).

Quality of Life impairment due to opiates Quality of Life impairment due to opiates side effects.side effects.

Page 10: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

OsteoporosisOsteoporosis

T1: signal reduction in D 12.

STIR: increased signal suggesting recent fracture.

Page 11: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

TumorsTumors

High risk of vertebral collapse.High risk of vertebral collapse.

Intractable pain.Intractable pain.

Marked side effects to opiates: blurred Marked side effects to opiates: blurred vision, bladder / bowel disorders, vision, bladder / bowel disorders, confinement to bed rest.confinement to bed rest.

Palliative treatment in terminal patients.Palliative treatment in terminal patients.

Page 12: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

Malignant TumorsMalignant Tumors

T1: signal reduction in vertebral body and posterior elements

+ C: increased signal

Page 13: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

Note that:Note that:

Most of skeletal metastasis occur in Most of skeletal metastasis occur in spine.spine.

Up to 10% of cancer patients present Up to 10% of cancer patients present symptomatic spine metastasis.symptomatic spine metastasis.

Course of local disease may be painful Course of local disease may be painful and invalidating.and invalidating.

Page 14: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

General Exclusion CriteriaGeneral Exclusion Criteria

Local / systemic infection.Local / systemic infection.

Recent fracture of posterior vertebral wall.Recent fracture of posterior vertebral wall.

Coagulation disorders.Coagulation disorders.

Poor general conditions.Poor general conditions.

Vertebral collapse > 80 – 90%.Vertebral collapse > 80 – 90%.

Page 15: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

Particular Exclusion CriteriaParticular Exclusion Criteria

Osteoporosis.Osteoporosis.

Adequate response to Adequate response to medical treatment.medical treatment.

Lack of radiological Lack of radiological progression of progression of fracture.fracture.

CancerCancer::

Advanced systemic Advanced systemic disease.disease.

Progression to spinal Progression to spinal channel.channel.

Page 16: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

Vertebral ApproachesVertebral Approaches(will vary according to surgeon’s specialty and experience)(will vary according to surgeon’s specialty and experience)

Cervical Spine: Cervical Spine: Anterior.Anterior.

Dorsal Spine: Dorsal Spine: Transpedicular.Transpedicular.

Lumbar Spine: Lumbar Spine: Transpedicular.Transpedicular.

Lateral.Lateral.

Page 17: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

Alternative ApproachesAlternative Approaches

Latero-transpedicular.Latero-transpedicular.

Latero-antepedicular.Latero-antepedicular.

Laterovertebral.Laterovertebral.

Page 18: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

EquipmentEquipment

Page 19: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

Fixed “C” ArmFixed “C” Arm

Advantages: Better image qualityEasier operation

Disadvantages:High operational costsUse subject to availability

Page 20: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

Mobile “C” ArmMobile “C” Arm

Advantages:Low operational costsAvailability

Disadvantages:Lesser image qualityMore difficult operation

Page 21: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

Immediate access to:Immediate access to:

CT Scan and / or RMI.CT Scan and / or RMI.ICU.ICU.Operating Room.Operating Room.

Must be available for the treatment of Must be available for the treatment of potential complicationspotential complications

Page 22: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

Local

GeneralNeurolepto

AnestesiaAnestesia

Election will depend on surgeon’s experience and characteristics of patient.

Page 23: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

Intraoperative MonitoringIntraoperative Monitoring

EKG.EKG.

OO22 Saturation Saturation (early diagnosis of pleural lesion).(early diagnosis of pleural lesion).

Pressurometry Pressurometry (occasional vagal raction).(occasional vagal raction).

During Local Anesthesia, Oxygen mask will During Local Anesthesia, Oxygen mask will provide sensation of comfort to patient.provide sensation of comfort to patient.

Page 24: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

Main advantages of Local Main advantages of Local AnesthesiaAnesthesia

Allows the surgeon to communicate with the Allows the surgeon to communicate with the patient.patient.

Benefits:Benefits:Early diagnosis of lesions (radicular / pleural) Early diagnosis of lesions (radicular / pleural) which might not be diagnosed otherwise.which might not be diagnosed otherwise.Determine cement injection speed.Determine cement injection speed.Anticipate corrective measures.Anticipate corrective measures.Abort the procedure.Abort the procedure.

Page 25: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

VideoVideo(Actual Procedure under Local Anesthesia)(Actual Procedure under Local Anesthesia)

Page 26: Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon

ConclusionsConclusions

PV is a Minimally Invasive Procedure.PV is a Minimally Invasive Procedure.Surgical Technique may be acquired in a Surgical Technique may be acquired in a short time.short time.PV may be performed on outpatients.PV may be performed on outpatients.Excellent tolerance to Local Anesthesia.Excellent tolerance to Local Anesthesia.May be combined with instrumental May be combined with instrumental arthrodesis of the spine.arthrodesis of the spine.Short and Long Term results are Short and Long Term results are encouraging.encouraging.